AACR COVID-19 and Cancer Meeting to Feature Anthony Fauci as Keynote Speaker
The American Association for Cancer Research (AACR) will host a virtual meeting on COVID-19 and cancer July 20-22, 2020. Registration is complimentary for credentialed members of the media. Contact Kathleen Venango at [email protected] to register.
The AACR Virtual Meeting: COVID-19 and Cancer will feature presentations from government officials, academics, and industry leaders who are on the cutting edge of research related to COVID-19 and cancer. Highlights include:
Monday, July 20
- Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, will present a keynote address titled “Coronavirus infections: More than just the common cold” at 10 a.m. ET.
- Benjamin tenOever, PhD, Icahn School of Medicine at Mount Sinai, will present a talk titled “The crosstalk between cellular transformation and the response to SARS-CoV-2 infection.”
- Kizzmekia S. Corbett, PhD, National Institute of Allergy and Infectious Diseases, will speak on COVID-19 vaccine development. Her presentation is titled “Rapid SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness.”
- Louis M. Staudt, MD, PhD, National Cancer Institute, will present his talk, “Inhibition of Bruton Tyrosine Kinase in patients with severe COVID-19,” during a session on cancer drug repurposing to treat COVID-19.
Tuesday, July 21
- Solange Peters, MD, PhD, CHU Vaudois, Lausanne, Switzerland, will present a keynote address titled “Flexibility to sustain solidity: Addressing new vulnerabilities in cancer at the time of COVID-19.”
- Kevan Shokat, PhD, University of California, San Francisco, will present a talk titled “Leveraging new insights from cancer drug discovery to target viral host factors.”
- Arthur Caplan, PhD, NYU Langone Health, will present a talk titled “Ethics, cancer and COVID.”
- Douglas R. Lowy, MD, National Cancer Institute, will discuss COVID-19 diagnostics development in a presentation titled “When cancer research goes viral.”
- Patrick D. Hsu, PhD, University of California, Berkeley, will discuss CRISPR tests for the virus.
Wednesday, July 22
- John M. Carethers, MD, University of Michigan, will discuss cancer health disparities and COVID-19.
- Otis W. Brawley, MD, Johns Hopkins University, will present a talk on cancer prevention and early detection during the pandemic.
- Trevor Bedford, PhD, Fred Hutchinson Cancer Research Center, will give a keynote address on genomic tracking of the virus’s evolution and spread.
- Norman E. Sharpless, MD, director of the National Cancer Institute, will offer remarks and participate in a closing roundtable with AACR President Antoni Ribas, MD, PhD; AACR President-Elect David A. Tuveson, PhD, and AACR Past President (2018-2019) Elizabeth M. Jaffee, MD.
Sessions will include symposia and forums on a wide variety of timely topics.
Meeting Program Chair and AACR President-Elect David A. Tuveson, PhD, will moderate two symposia featuring invited talks and highly rated proffered papers:
SYMPOSIUM 1: INTERSECTION OF THE BIOLOGY SARS-COV-2 AND CANCER
Monday, July 20, 10:50 a.m.-12:50 p.m. ET
- The crosstalk between cellular transformation and the response to SARS-CoV-2 infection
Benjamin tenOever, Icahn School of Medicine at Mount Sinai
- Therapeutic targeting of TMPRSS2 and ACE2 as a potential strategy to combat COVID-19
Irfan A. Asangani, University of Pennsylvania
- Optimizing treatment for COVID-19 using computational modelling: Implications for cancer patients
Lance L. Munn, Harvard Medical School
- A prediction of prostate cancer deaths spiking by SARS-CoV-2 infection
Alakesh Bera, Uniformed Services University
- Systems approaches reveal shared pathways affected in SARS-CoV-2 infection and cancer
Nevan Krogan, University of California, San Francisco
SYMPOSIUM 8: COVID-19 DIAGNOSTICS DEVELOPMENT
Tuesday, July 21, 2:20-4:20 p.m. ET
- When cancer research goes viral
Douglas R. Lowy, National Cancer Institute
- Highly sensitive and full-genome interrogation of SARS-CoV-2 using multiplexed PCR enrichment followed by next-generation sequencing
Chenyu Li, Paragon Genomics
- CRISPR tests for SARS-CoV-2
Patrick D. Hsu, University of California, Berkeley
- Rapid isothermal SARS-CoV-2 detection using RT-LAMP
Brian Rabe, Harvard Medical School
Forums featuring conversations among leading experts will include:
- Regulatory and Operational Implications of Cancer Clinical Trial Changes During COVID-19
- How Will We Bring Patients Back to the Clinic?
- How Cancer Researchers Are Applying Their Talents to COVID-19 Issues
- Public-Private Partnerships Poised to Address COVID-19
- Health Disparities
The full program is available here.
To register as press or for help accessing the virtual meeting platform, please contact Kathleen Venango at [email protected].